11-080
TDZD-8
ProSci
DESCRIPTION
TDZD-8 is a non-ATP competitive selective inhibitor of the serine/threonine kinase glycogen synthase kinase 3β (GSK3β; IC50 = 2µM), binding to the active site of GSK3β. It does not significantly affect the activities of Cdk-1/cyclin B, CK-II, cAMP-dependent protein kinase or protein kinase C (IC50s = >100 µM), but inhibits PKC and Flt-3 activities (IC50 = 1.4-5.5µM and 673nM, respectively).
TDZD-8 has been used to study the role of GSK3β during stem cell differentiation as well as in cell and animal models of Alzheimer’s disease and other neurodegenerative disorders.
TDZD-8 is a potent anti-proliferative and pro-apoptotic agent of glioma cells in vitro and in vivo. These effects are associated with an early activation of extracellular signal-regulated kinase (ERK), which is followed by an increased expression of the early growth response-1 (EGR-1) and p21.
TDZD-8 potentially inhibits the 33.8-kDa Main protease (Mpro)/3C-like protease of SARS-CoV-2, consequently inhibiting viral transcription and replication and possibly inhibiting spread of COVID-19.
DETAILS
- Cas: 327036-89-5
- Purity: greater than or equal to 98% (HPLC)
- Smiles: O=C(N1CC2=CC=CC=C2)N(C)SC1=O
- Formula: C10H10N2O2S
- Storage: Short Term Storage: +4C. Long Term Storage: -20C. Handling Advice: Keep cool and dry. Use/Stability: Stable for at least 2 years after receipt when stored at -20C.
- Identity: Determined by 1H-NMR.
- Shipping: Room Temp
- Inchi Key: JDSJDASOXWCHPN-UHFFFAOYSA-N
- Solubility: Soluble in DMSO (20mg/ml), DMF (20mg/ml) or ethanol (20mg/ml).
- Physical State: Lyophilized
- Additional Names: NP 01139; 2-Methyl-4-(phenylmethyl)-1,2,4-thiadiazolidine-3,5-dione
- Predicted Molecular Weight: 222.3
Equivalent Items
| ... Loading